888集团(中国)电子游戏有限公司
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
旧版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Announcement on Rabeprazole Sodium Enteric-coated Tablets (20mg) Passing the Gen
2023-07-14
Overseas Regulatory Announcement-Announcement on New Drug Specifications and Pas
2023-07-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
2023-07-03
Articles of Association
2023-06-26
Overseas Regulatory Announcement-Announcement on Alogliptin Benzoate Obtaining Notification of Approval of Marketing Application for Chemical Raw Material Drugs
2023-06-20
Overseas regulatory announcement-Announcement on Rabeprazole Sodium Enteric-coat
2023-06-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
2023-06-01
Proposed Amendments To The Articles of Association And Notice of The Annual Gene
2023-05-23
Notice of The Annual General Meeting
2023-05-23
Proxy Form for 2022 Annual General Meeting
2023-05-23
<
...
7
8
9
10
11
12
13
...
>